COF
63
-4
ADI
45
-5
NI
73
3
AVGO
35
-2
DVN
29
4
LOW
58
2
TEL
74
3
T
48
3
DOV
73
4
NSC
64
2
AIZ
78
2
CNP
50
-2
DUK
50
-2
XEL
65
-2
HPE
70
2
XRX
34
-3
CMS
58
-2
DGX
48
-3
MS
80
-3
RCL
88
-2
COF
63
-4
ADI
45
-5
NI
73
3
AVGO
35
-2
DVN
29
4
LOW
58
2
TEL
74
3
T
48
3
DOV
73
4
NSC
64
2
AIZ
78
2
CNP
50
-2
DUK
50
-2
XEL
65
-2
HPE
70
2
XRX
34
-3
CMS
58
-2
DGX
48
-3
MS
80
-3
RCL
88
-2
Financhill
Back

Neurogene Stock Predictions

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Sell
5

NGNE
Neurogene

Last Price:
39.99
Seasonality Move:
50.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.

Neurogene Stock Forecast

  • Over the next 52 weeks, Neurogene has on average historically risen by 62.7% based on the past 10 years of stock performance.
  • Neurogene has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Neurogene Stock Undervalued?
    The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Neurogene Stock Go Up Next Year?

  • Over the next 52 weeks, Neurogene has on average historically risen by 62.7% based on the past 10 years of stock performance.

Neurogene Stock Rating

Sell
5
Neurogene (NGNE) is a Sell

Is Neurogene overpriced?

  • Neurogene has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Neurogene Stock Price History

Is NGNE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com

52-Week Data

52-Week High:
74.49
52-Week Low:
12.49

Prediction Charts

Market Cap:
513.77M
Price in USD:
39.54
Volume:
588.44K
Beta:
-1.26

Technical Analysis

SMA50:
46.66
SMA100:
42.31
SMA200:
38.93
52-Wk Change:
194.2%

Stock Predictions

  • Is Neurogene stock public?
    Yes, Neurogene is a publicly traded company.
  • What is the Neurogene stock quote today?
    The Neurogene stock price is 39.54 USD today.
  • How to buy Neurogene stock online?
    You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-25 48.45 48.37 50.85 47.76
Oct-28 49.14 45.93 51.19 45.80
Oct-29 45.40 45.27 46.94 44.49
Oct-30 45.08 43.58 46.01 43.58
Oct-31 43.56 44.01 44.31 42.23
Nov-1 44.73 46.07 46.23 44.47
Nov-4 56.17 66.00 73.59 55.00
Nov-5 65.44 64.40 65.64 55.88
Nov-6 66.36 63.94 66.36 62.13
Nov-7 63.99 69.50 70.80 62.84
Nov-8 69.78 68.21 71.60 66.60
Nov-11 70.04 71.53 74.49 69.49
Nov-12 48.28 40.00 49.37 35.60
Nov-13 39.67 39.54 41.33 39.08

Neurogene Earnings

Neurogene Earnings Report: Per Share Neurogene Earnings Q1 Q2 Q3 and Q4 last year and next year.

Neurogene Forecast Revenue Growth

Neurogene Stock Analysis: Historical quarterly revenues per share for Neurogene and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

* Neurogene stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.